Genocea Biosciences Inc Net debt/EBITDA
Cos'è Net debt/EBITDA di Genocea Biosciences Inc?
Net debt/EBITDA di Genocea Biosciences Inc è 2.20
Qual è la definizione di Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA di aziende nel Health Care settore su NASDAQ rispetto a Genocea Biosciences Inc
Cosa fa Genocea Biosciences Inc?
Genocea's mission is to conquer cancer by developing personalized cancer immunotherapies in multiple tumor types. Our unique ATLAS™ platform comprehensively profiles each patient's T cell responses to potential targets, or antigens, on the tumor. ATLAS enables us to optimize the neoantigens for inclusion in our immunotherapies and exclude inhibitory antigens, Inhibigens™, that can exert an immunosuppressive effect. We are advancing two ATLAS-enabled programs: GEN-009, our neoantigen vaccine and GEN-011, our neoantigen-specific cell therapy using T cells derived from peripheral blood.
Aziende con net debt/ebitda simili a Genocea Biosciences Inc
- Hydratec Industries NV ha Net debt/EBITDA di 2.19
- AngloGold Ashanti ha Net debt/EBITDA di 2.20
- Goodman Stapled Securities ha Net debt/EBITDA di 2.20
- Valdor Technology International ha Net debt/EBITDA di 2.20
- Karrie International ha Net debt/EBITDA di 2.20
- The Panoply Plc ha Net debt/EBITDA di 2.20
- Genocea Biosciences Inc ha Net debt/EBITDA di 2.20
- GoPro ha Net debt/EBITDA di 2.20
- United Parcel Service ha Net debt/EBITDA di 2.21
- Qingdao Richen Foods Co ha Net debt/EBITDA di 2.21
- S&P Global ha Net debt/EBITDA di 2.22
- United Parcel Service ha Net debt/EBITDA di 2.22
- Alltronics ha Net debt/EBITDA di 2.22